117 related articles for article (PubMed ID: 2767242)
1. Antibody response to pneumococcal vaccine in patients with early stage Hodgkin's disease.
Frederiksen B; Specht L; Henrichsen J; Pedersen FK; Pedersen-Bjergaard J
Eur J Haematol; 1989 Jul; 43(1):45-9. PubMed ID: 2767242
[TBL] [Abstract][Full Text] [Related]
2. Response to pneumococcal polysaccharide vaccine in patients with untreated Hodgkin's disease. Children's Cancer Study Group Report.
Addiego JE; Ammann AJ; Schiffman G; Baehner R; Higgins G; Hammond D
Lancet; 1980 Aug; 2(8192):450-2. PubMed ID: 6106099
[TBL] [Abstract][Full Text] [Related]
3. Type-specific anti-pneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients.
Grimfors G; Björkholm M; Hammarström L; Askergren J; Smith CI; Holm G
Eur J Haematol; 1989 Nov; 43(5):404-10. PubMed ID: 2612613
[TBL] [Abstract][Full Text] [Related]
4. Response to pneumococcal vaccine among children with Hodgkin's disease.
Donaldson SS; Vosti KL; Berberich FR; Cox RS; Kaplan HS; Schiffman G
Rev Infect Dis; 1981; 3 Suppl():S133-43. PubMed ID: 6895119
[TBL] [Abstract][Full Text] [Related]
5. Antibody response of patients with Hodgkin's disease to protein and polysaccharide antigens.
Siber GR; Weitzman SA; Aisenberg AC
Rev Infect Dis; 1981; 3 Suppl():S144-59. PubMed ID: 7280445
[TBL] [Abstract][Full Text] [Related]
6. Antibody response to vaccination with pneumococcal capsular polysaccharides in splenectomized children.
Pedersen FK; Henrichsen J; Schiffman G
Acta Paediatr Scand; 1982 May; 71(3):451-5. PubMed ID: 7136661
[TBL] [Abstract][Full Text] [Related]
7. A longitudinal study of class and subclass antibody response to pneumococcal vaccination in splenectomized individuals with special reference to patients with Hodgkin's disease.
Grimfors G; Söderqvist M; Holm G; Lefvert AK; Björkholm M
Eur J Haematol; 1990 Aug; 45(2):101-8. PubMed ID: 2209812
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease.
Chan CY; Molrine DC; George S; Tarbell NJ; Mauch P; Diller L; Shamberger RC; Phillips NR; Goorin A; Ambrosino DM
J Infect Dis; 1996 Jan; 173(1):256-8. PubMed ID: 8537671
[TBL] [Abstract][Full Text] [Related]
9. Response of patients with Hodgkin's disease to pneumococcal vaccine.
Minor DR; Schiffman G; McIntosh LS
Ann Intern Med; 1979 Jun; 90(6):887-92. PubMed ID: 36021
[TBL] [Abstract][Full Text] [Related]
10. An enzyme-linked immunosorbent assay suitable for the routine estimation of specific immunoglobulin G responses to polyvalent pneumococcal polysaccharide vaccine in humans.
Nieuwhof WN; Hodgen AN
J Immunol Methods; 1985 Nov; 84(1-2):197-202. PubMed ID: 4067315
[TBL] [Abstract][Full Text] [Related]
11. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy.
Shatz DV; Schinsky MF; Pais LB; Romero-Steiner S; Kirton OC; Carlone GM
J Trauma; 1998 May; 44(5):760-5; discussion 765-6. PubMed ID: 9603075
[TBL] [Abstract][Full Text] [Related]
12. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine.
Sorensen RU; Leiva LE; Giangrosso PA; Butler B; Javier FC; Sacerdote DM; Bradford N; Moore C
Pediatr Infect Dis J; 1998 Aug; 17(8):685-91. PubMed ID: 9726341
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal vaccine failures. Two case reports and review.
Sumaya CV; Harbison RW; Britton HA
Am J Dis Child; 1981 Feb; 135(2):155-8. PubMed ID: 7468549
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines.
Petrasch S; Kühnemund O; Reinacher A; Uppenkamp M; Reinert R; Schmiegel W; Lütticken R; Brittinger G
Clin Diagn Lab Immunol; 1997 Nov; 4(6):635-8. PubMed ID: 9384280
[TBL] [Abstract][Full Text] [Related]
15. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants.
Ahman H; Käyhty H; Tamminen P; Vuorela A; Malinoski F; Eskola J
Pediatr Infect Dis J; 1996 Feb; 15(2):134-9. PubMed ID: 8822286
[TBL] [Abstract][Full Text] [Related]
16. Immunization of immunosuppressed patients with pneumococcal polysaccharide vaccine.
Ammann AJ; Schiffman G; Addiego JE; Wara WM; Wara DW
Rev Infect Dis; 1981; 3 Suppl():S160-7. PubMed ID: 7280446
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the antibody response to pneumococcal vaccine in high-risk populations.
Landesman SH; Schiffman G
Rev Infect Dis; 1981; 3 Suppl():S184-97. PubMed ID: 7025158
[TBL] [Abstract][Full Text] [Related]
18. Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for determination of anti-pneumococcal polysaccharide antibodies.
Pedersen FK; Henrichsen J; Schiffman G
Acta Pathol Microbiol Immunol Scand C; 1983 Aug; 91(4):251-5. PubMed ID: 6356780
[TBL] [Abstract][Full Text] [Related]
19. Decline of serum antibody in splenectomized children after vaccination with pneumococcal capsular polysaccharides.
Giebink GS; Le CT; Schiffman G
J Pediatr; 1984 Oct; 105(4):576-82. PubMed ID: 6481533
[TBL] [Abstract][Full Text] [Related]
20. Serum antibody responses to vaccination with 23-valent pneumococcal vaccine in splenectomized patients.
Reinert RR; Kaufhold A; Kühnemund O; Lütticken R
Zentralbl Bakteriol; 1994 Nov; 281(4):481-90. PubMed ID: 7727895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
